Dr. Fadlo Khuri, M.D.

Professor and Chair, Department of Hematology and Medical Oncology at Emory Winship Cancer Institute

Deputy Director for Clinical and Translational Research, Roberto C. Goizueta Distinguished Chair in Cancer Research

Dr. Khuri received his B.S. degree in Biology from the Yale University and his M.D. from Columbia University. He did his internship/ residency at Boston City Hospital and a fellowship in hematology and medical oncology at Tufts University/ New England Medical Center. Upon completing his fellowship, he began his career in the Department of Thoracic/ Head and Neck Medical Oncology at University of Texas, MD Anderson Cancer Center in Houston Texas.

Currently, Dr. Khuri is the Deputy Director for Clinical and Translational Research, Roberto C. Goizueta Chair in Cancer Research, Professor and Chair of Hematology and Oncology at the Winship Cancer Institute of Emory University. His focus in cancer research is to develop molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for cancer patients. In addition, he is interested in the development of viral, oncolytic, and gene therapy strategies in lung cancer and head and neck cancer. He is an active member of the American Association for Cancer Research, American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer. Dr. Khuri authored more than 120 articles for peer-reviewed journals. He serves on the editorial board for Archives of Otolaryngology, Head and Neck Surgery, Cancer, Journal of Clinical Oncology, Clinical Cancer Research, and American Journal of Clinical Oncology, and reviews manuscripts for these and several other journals. He has been the recipient of an American Cancer Society Career Development Award, numerous DoD and NIH/ NCI grants, as well as funding from the State of Georgia. He has been honored by induction into the American Society of Clinical Investigation, inclusion in the Best Doctors in America and by receiving the Naji Sahyoun Memorial Award from the Middle East Medical Assembly. He has been named a Georgia Cancer Coalition Distinguished Scholar every year since 2003. He is a regular speaker and moderator at international symposia on the treatment and prevention of lung and head and neck cancers.

In the Spring of 2006, Emory University received funding for a five-year NCI program project in lung cancer entitled “Targeting cell signaling in lung cancer to enhance therapeutic efficacy” of which Dr. Khuri is the principal investigator. In 2008, investigators at Emory received funding for a head and neck SPORE application. Dr. Khuri is the co-principal investigator of this grant and leads one scientific project and the career development program of the SPORE.

Go Back